Yorihisa Tanaka

Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl] propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivo

Keiichi Matsuda, Yorihisa Tanaka, Shigeru Ushiyama et al. · Biochemical Pharmacology · 1984 · 47 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Stereoselective pharmacokinetics of RS‐8359, a selective and reversible MAO‐A inhibitor, by species‐dependent drug‐metabolizing enzymes

Wataru Takasaki, Mayumi Yamamura, Akiko Nozaki et al. · Chirality · 2005 · 37 citations

Medicine, Pharmacokinetics, Pharmacology +15

Optical inversion of (2R)- to (2S)-isomers of 2-(4-(2-oxocyclopentylmethyl)-phenyl)propionic acid (loxoprofen), a new anti-inflammatory agent, and its monohydroxy metabolites in the rat.

Hisomu NAGASHIMA, Yorihisa Tanaka, Hidetoshi Watanabe et al. · Chemical and Pharmaceutical Bulletin · 1984 · 35 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +12

Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase

Kunio Itoh, Mayumi Yamamura, Wataru Takasaki et al. · Biopharmaceutics & Drug Disposition · 2006 · 32 citations

Medicine, Medicinal Chemistry, Pharmacology +15

Substrate Selectivity of Monoamine Oxidase A, Monoamine Oxidase B, Diamine Oxidase, and Semicarbazide-Sensitive Amine Oxidase in COS-1 Expression Systems

Yoshinori Ochiai, Kunio Itoh, Eiichi Sakurai et al. · Biological and Pharmaceutical Bulletin · 2006 · 32 citations · Full text

Life Sciences, Biochemistry, Pharmacology +13